Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiawei Guizhi Jia Longgu Muli Decoction is a modified Traditional Chinese Medicine (TCM) formula based on the classic Guizhi Jia Longgu Muli Decoction (Cinnamon Twig plus Dragon Bone and Oyster Shell Decoction). It is being developed as an adjunctive therapy for cancer-related insomnia (CRI) in patients with malignant tumors. The formula is designed to harmonize the 'Ying' and 'Wei' systems, nourish the heart, and calm the spirit by anchoring the 'Yang' with mineral and shell components. In clinical practice, it is often administered as granules in combination with standard hypnotic medications to improve sleep quality and mitigate the side effects of conventional sedatives. The 'Jiawei' (modified) designation indicates the addition of specific herbs to the base formula to tailor the treatment for the complexities of cancer-related symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiawei guizhi jia longgu muli decoction.